Orexin and Alzheimer’s Disease: A New Perspective
Yoo Hyun Um, Hyun Kook Lim
Psychiatry Investig. 2020;17(7):621-626.   Published online 2020 Jun 11     DOI: https://doi.org/10.30773/pi.2020.0136
Pharmacological Management of Apathy in Dementia
Laiba Azhar, Raphael W. Kusumo, Giovanni Marotta, Krista L. Lanctôt, Nathan Herrmann
CNS Drugs.2022; 36(2): 143.     CrossRef
Orexin receptors: Targets and applications
Subhiksha Subramanian, Mirunalini Ravichandran
Fundamental & Clinical Pharmacology.2022; 36(1): 72.     CrossRef
Orexin A peptidergic system: comparative sleep behavior, morphology and population in brains between wild type and Alzheimer’s disease mice
Peng Zhao, Yaqian You, Zhe Wang, Yanjun Zhou, Gaoshang Chai, Gen Yan, Zhewu Jin, Qing Wang, Hongxu Sun
Brain Structure and Function.2022; 227(3): 1051.     CrossRef
Recent trends of natural based therapeutics for mitochondria targeting in Alzheimer’s disease
Ashish Dhiman, Mayank Handa, Munindra Ruwali, Dhirendra Pratap Singh, Prashant Kesharwani, Rahul Shukla
Mitochondrion.2022; 64: 112.     CrossRef
Sleep–Wake Disorders in Alzheimer’s Disease: A Review
Yu-Ying Sun, Zhun Wang, He-Yan Zhou, Han-Chang Huang
ACS Chemical Neuroscience.2022; 13(10): 1467.     CrossRef